SHARONBIO

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on May 30, 2023.

Un-audited Financial Results for the quarter and half year ended September 30, 2022

Sharon Bio-Medicine Limited has informed the Exchange about Board Meeting held on 12-Aug-2022 to consider financial statements for the period ended June 2022

Sharon Bio-Medicine Limited has informed the Exchange about Board Meeting held on 17-May-2022 to consider financial statements for the period ended March 2022

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on February 07, 2022.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on Jun 23, 2021.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on February 12, 2021.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on November 11, 2020.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on September 11, 2020.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on Jun 26, 2020.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on February 12, 2020.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on November 14, 2019.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on August 14, 2019.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on May 24, 2019.

Financial Results for the quarter ended on June 30, 2018.

Financial Results for the quarter and year ended on March 31, 2018.

Sharon Bio-Medicine Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on April 24, 2017 has took note of the following : Mr. Harish Palecanda and Dr. Nivedita Patil has tendered their resignation as an Independent Directors on the Board of the Company with effect from April 01, 2017.

Sharon Bio-Medicine Limited has informed the Exchange regarding the Outcome of Board Meeting of the Company held on August 11, 2016.

Sharon Bio-Medicine Limited has informed the Exchange that as decided in the Meeting of the Board of Directors of the Company held on June 21, 2016, for which intimation was already given to you, the Board of Directors: 1) Discussed the current financial position of the Company and decided to introduce more profitable products increase capacity utilization and get the business to move in the regulated markets specifically the United States of America.

Sharon Bio-Medicine Limited has informed the Exchange that the Board of Directors at their meeting held on January 12, 2016 have discussed the below:1. Closure of the subsidiary company M/s Yusur International FZE.2. Acceptance of Resignation of Mr. Mohan Kala and Mr. Madhav Sapre from the office of Director w.e.f December 31, 2015.

Sharon Bio-Medicine Limited has informed the Exchange regarding outcome of meeting of the Board of Directors of the Company held on June 10, 2015.

Sharon Bio-Medicine Limited has informed the Exchange regarding the Outcome of Board Meeting of the Company held on March 30, 2015.

Sharon Bio-Medicine Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on October 20 2014 has resolved and allotted 1,61,11,000 Warrants to the Promoter group on Preferential basis in compliance of SEBI (Issue of Capital and Disclosure Requirements) Regultions, 2009.

Sharon Bio-Medicine Limited has informed the Exchange regardiing the Outcome of Board Meeting of the Company.

Sharon Bio-Medicine Limited has informed the Exchange that the Board of Directors have approved issue of upto 1,80,00,000 warrants, convertible into equity shares to Promoter Group at a price to be calculated as per SEBI ICDR regulations, subject to a minimum price of Rs. 45 per warrant/ share ( Rs 2 towards face value and balance towards premium), subject to the consent of the Members of the Company to be obtained through Postal Ballot. Board approved the Postal Ballot notice to be sent to the Members.

Sharon Bio-Medicine Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 24, 2014, has resolved the following: 1. Allotment of 52784500 bonus equity shares of Rs. 2/- each. 2. Severally authorizing Ms. Savita Gowda, Managing Director of the Company and Mr. Mohan Kala, Director of the Company, to do all the acts and deeds in the above regard. 3. Authority to Share Transfer Agents of the Company, Link Intime India Pvt. Ltd. to issue share certificates.

Sharon Bio-Medicine Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 26, 2013, has resolved the following: (a) The old Bonds of USD $ 16.5 Million has been extended for further period of 5 Five Years and also resolved to issue the new Bonds USD $ 8.046 Million which shall be issued in lieu of interest accrued on the old bonds. The floor price of new bonds is Rupees 288.49, the conversion price of new bonds shall not be below the floor price.